Pharmacokinetics of pazopanib: a review of the determinants, influencing factors and the clinical importance of therapeutic drug monitoring
Pazopanib exhibits large variability in systemic exposure and consequently, achieving systemic exposures within a therapeutic range for optimal efficacy while minimizing toxicity, can be challenging when a fixed dose is used. Therefore, therapeutic drug monitoring may be a promising tool to optimize the efficacy of pazopanib while limiting drug-related toxicities, through personalized dose adjustments guided by monitoring plasma pazopanib concentrations. Further exploration into the influence of additional factors on pazopanib pharmacokinetics is essential for advancing pharmacokinetic-guided dosing strategies and improve treatment outcomes.
Authors
- Andrew J. McLachlan (ORCID: https://orcid.org/0000-0003-4674-0242)
- Annette S. Gross (ORCID: https://orcid.org/0000-0001-9567-0127)
- Nicki M. Kyriacou
Institutions
- The University of Sydney (AU)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1093/jpp/rgaf095
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00